Cocrystal Pharma
COCP
34 hedge funds and large institutions have $7.9M invested in Cocrystal Pharma in 2022 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 10 reducing their positions, and 7 closing their positions.
0.06% less ownership
Funds ownership: 1.29% → 1.23% (-0.06%)
3% less funds holding
Funds holding: 35 → 34 (-1)
14% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 7
19% less capital invested
Capital invested by funds: $9.78M → $7.9M (-$1.88M)
70% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WWM
Western Wealth Management
Golden,
Colorado
|
+$12.6K |
| 2 |
State Street
Boston,
Massachusetts
|
+$10.5K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$8.94K |
| 4 |
VF
Virtu Financial
New York
|
+$7.89K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$4.66K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LPL Financial
San Diego,
California
|
-$130K |
| 2 |
Renaissance Technologies
New York
|
-$110K |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
-$69.9K |
| 4 |
JP Morgan Chase
New York
|
-$27.5K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$26K |
COCP Hedge Fund Activity: Q1 2022 in Review
34 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Cocrystal Pharma (COCP) for Q1 2022, worth a combined $7.9M — down 19% from $9.78M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of COCP and 6 opened new positions — a net loss of 1 holder — while 10 trimmed existing stakes and 3 added.
The largest buyer was Western Wealth Management, opening a new position worth an estimated $12.6K. The largest seller was LPL Financial, exiting entirely with an estimated $130K sold.
- 34 institutional investors held Cocrystal Pharma (COCP) as of Q1 2022, down from 35 in Q4 2021.
- Funds reported $7.9M of Cocrystal Pharma stock for Q1 2022, down 19% quarter-over-quarter.
- 6 funds opened new Cocrystal Pharma positions in Q1 2022 and 7 closed out, a net change of -1 holder.
- The largest Cocrystal Pharma buyer in Q1 2022 was Western Wealth Management, an estimated $12.6K added.
- The largest Cocrystal Pharma seller in Q1 2022 was LPL Financial, an estimated $130K sold.
Based on aggregated 13F filings for Q1 2022.